Development of a Nanostructured Platform for Identifying HER2-Heterogeneity of Breast Cancer Cells by Surface-Enhanced Raman Scattering

Biosensor technology has great potential for the detection of cancer through tumor-associated molecular biomarkers. In this work, we describe the immobilization of the recombinant humanized anti-HER2 monoclonal antibody (trastuzumab) on a silver nanostructured plate made by pulsed laser deposition (...

Descripción completa

Detalles Bibliográficos
Autores principales: Téllez-Plancarte, Alexandro, Haro-Poniatowski, Emmanuel, Picquart, Michel, Morales-Méndez, José Guadalupe, Lara-Cruz, Carlos, Jiménez-Salazar, Javier Esteban, Damián-Matsumura, Pablo, Escobar-Alarcón, Luis, Batina, Nikola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6071071/
https://www.ncbi.nlm.nih.gov/pubmed/30036967
http://dx.doi.org/10.3390/nano8070549

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6071071/
https://www.ncbi.nlm.nih.gov/pubmed/30036967
http://dx.doi.org/10.3390/nano8070549

Ejemplares similares